TSG101 and cancer: The direct competition between TSG101 and TSGΔ154-1054 for interaction with Tal demonstrates a novel mechanism for posttranslational protein regulation; and, by this means TSGΔ154-1054 is implicated in the TSG101-associated oncogenic events and therefore, be a potential target for cancer therapy.